Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$18.25

-0.35 (-1.88%)

08:03
10/12/16
10/12
08:03
10/12/16
08:03

Global Blood Therapeutics appoints Tricia Suvari as Chief Legal Officer

Global Blood Therapeutics announced the expansion of its management team with the appointment of Tricia Suvari as Chief Legal Officer. She previously served in several senior roles at CV Therapeutics.

GBT Global Blood Therapeutics
$18.25

-0.35 (-1.88%)

06/10/16
JANY
06/10/16
NO CHANGE
Target $71
JANY
Buy
Janney lowers bluebird bio target to $71 after 'compelling' peer data
Following new 90-day results from Global Blood Therapeutics (GBT) for its GBT440 drug in sickle cell disease patients, Janney Capital analyst Debjit Chattopadhyay said "the onus is now on" bluebird bio (BLUE) to rapidly advance process improvements in the clinic, adding that the "implications of the ASH16 data for the Lentiglobin platform cannot be understated." Based on revised market share assumptions, Chattopadhyay lowered his fair value estimate on bluebird to $71 from $91 but maintains a Buy rating on the stock.
06/13/16
LEER
06/13/16
NO CHANGE
Target $67
LEER
Outperform
bluebird can co-exist with rivals in hemoglobinopathies market, says Leerink
Leerink analyst Michael Schmidt says bluebird bio (BLUE) shares were weak on Friday following the presentation of competitor data from Global Blood Therapeutics (GBT) and Acceleron (XLRN) in sickle-cell disease and beta-thalassemia, respectively, at the European Hematology Association's congress. However, the analyst believes that given the differences between the treatment approaches and the likely different effect size and target patient population, both products could co-exist with bluebird's LentiGlobin within the hemoglobinopathies market. Schmidt reiterates an Outperform rating and $67 price target on bluebird's shares.
06/17/16
EAMC
06/17/16
NO CHANGE
Target $58
EAMC
Buy
Global Blood Therapeutics GBT440 data is promising, says Empire
Empire analyst Dr. Cathy Reese said GBT440's EHA 2016 Phase I/II data presented on June 10 at the the European Hematology Association's 2016 annual meeting in Copenhagen, Denmark looks promising. Reese said the single center data in 27 patients provides reassurance that GBT440 has potential to be a successful therapy for SCD patients. While the GBT440 data was from an early-stage trial and in a limited number of patients, GBT440 seemed to demonstrate a relatively steady improvement in the patients' hemolysis markers and exhibited acceptable tolerability. The next step in GBT440's development should be a meeting with the FDA this summer to begin to formulate the next clinical development steps for the drug. Dr. Reese rates Global Blood a Buy with a $58 price target on shares.
09/30/16
WELS
09/30/16
INITIATION
WELS
Outperform
Global Blood Therapeutics initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started Global Blood Therapeutics with an Outperform rating and $75-$81 price target range. The analyst has a positive outlook for the company's hemoglobin modifier GBT440 in Sickle Cell Disease. He views GBT440 as a best-in-class hemoglobin modifier and estimates peak sales at $2.7B.

TODAY'S FREE FLY STORIES

UCFC

United Community Financial

$8.70

0.01 (0.12%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Earnings
United Community Financial reports Q1 adjusted EPS 9.9c, consensus 11c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MCRI

Monarch Casino

$29.25

-0.17 (-0.58%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Earnings
Monarch Casino reports Q1 diluted EPS 27c, consensus 28c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISI

Financial Institutions

$34.45

-0.15 (-0.43%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Earnings
Financial Institutions reports Q1 EPS 52c, consensus 51c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

WYNN

Wynn Resorts

$118.22

2.65 (2.29%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Hot Stocks
Wynn Resorts reports Q1 Macau revenues down 3.5% to $587M »

Reports Macau Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NUVA

NuVasive

$76.94

0.59 (0.77%)

16:13
04/25/17
04/25
16:13
04/25/17
16:13
Earnings
NuVasive sees FY17 non-GAAP EPS $2.00, consensus $2.02 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 18

    May

PNRA

Panera Bread

$313.72

-0.35 (-0.11%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Earnings
Panera Bread reports Q1 EPS $1.83, consensus $1.84 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SD

SandRidge Energy

$18.80

0.28 (1.51%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Initiation
SandRidge Energy initiated  »

SandRidge Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

CMG

Chipotle

$471.33

2.539 (0.54%)

16:12
04/25/17
04/25
16:12
04/25/17
16:12
Earnings
Chipotle backs FY17 SSS view of up in high-single digits »

Backs FY17 restaurant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$181.50

1.3 (0.72%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Illumina sees Q2 adjusted EPS 65c-70c, consensus 87c »

Sees Q2 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GPRO

GoPro

$9.18

0.17 (1.89%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Hot Stocks
GoPro says Susan Lyne joins board of directors »

GoPro announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 24

    May

  • 25

    May

CENX

Century Aluminum

$13.62

0.99 (7.84%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Century Aluminum reports Q1 EPS (5c), consensus (17c) »

Reports adjusted EBITDA1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NUVA

NuVasive

$76.94

0.59 (0.77%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
NuVasive reports Q1 non-GAAP EPS 38c, consensus 38c »

Reports Q1 revenue $250M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 18

    May

CMG

Chipotle

$471.15

2.36 (0.50%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Hot Stocks
Chipotle reports Q1 EPS $1.60, consensus $1.27 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$181.50

1.3 (0.72%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Illumina sees FY17 adjusted EPS $3.60-$3.70, consensus $3.64 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DDR

DDR Corp.

$12.40

0.185 (1.52%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
DDR Corp. reports Q1 EPS (16c), may not compare to consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ALGT

Allegiant Travel

$163.85

-1.2 (-0.73%)

16:11
04/25/17
04/25
16:11
04/25/17
16:11
Earnings
Allegiant sees Q2 TRASM increasing 1.5%-3.5% vs. Q2 last year »

Sees Q2 CASM ex fuel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Shutterfly sees 2017 EPS 45c-80c, consensus 59c »

Sees 2017 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

WYNN

Wynn Resorts

$118.22

2.65 (2.29%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Wynn Resorts reports Q1 EPS $1.24, consensus 96c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

PRGO

Perrigo

$67.80

0.745 (1.11%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Hot Stocks
Perrigo concludes some previous financial statements should not be relied upon »

Perrigo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Shutterfly sees Q2 EPS (55c)-(50c), consensus (49c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

RNG

RingCentral

$30.68

0.475 (1.57%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Hot Stocks
RingCentral CFO Clyde Hosein to leave company at end of May 2017 »

RingCentral announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 30

    May

ILMN

Illumina

$181.50

1.3 (0.72%)

16:10
04/25/17
04/25
16:10
04/25/17
16:10
Earnings
Illumina reports Q1 adjusted EPS 64c, consensus 64c »

Reports Q1 revenue $598M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SFLY

Shutterfly

$51.46

0.18 (0.35%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
Shutterfly reports Q1 EPS (98c), consensus (99c) »

Reports Q1 revenue $192M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

EQGP

EQT GP

$27.22

-0.34 (-1.23%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Hot Stocks
EQT GP raises quarterly distribution to 19.1c per unit »

EQT GP Holdings declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    May

RNG

RingCentral

$30.68

0.475 (1.57%)

16:09
04/25/17
04/25
16:09
04/25/17
16:09
Earnings
RingCentral reports Q1 adjusted EPS 3c, consensus 2c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.